Blackman Samuel C.
HEAD OF R&D at DAWN
- Sold, on record
- $6.6M
- Dollars the filings state
- Form 4 sales
- 35
- Latest Dec 10, 2024
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- DAWNDay One Biopharmaceuticals, Inc.HEAD OF R&D
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale DAWNRoutineJul 16 2024
Sold 20,000 shares at $16.01 ($320k)
Blackman Samuel C., HEAD OF R&D
10b5-1 planSold 1.8% of holdings ($18.3M position)1.1M shares left2x usual sizeFiling
- 2 Form 4 sale DAWNNo planAug 16 +31 days
Sold 2,232 shares at $14.00 ($31k)
Blackman Samuel C., HEAD OF R&D
No 10b5-1 planSold 0.2% of holdings ($15.8M position)1.1M shares left0.2x usual sizeFiling
- 3 Form 4 sale DAWNUnusualSep 10 +25 days
Sold 30,000 shares at $14.22 ($427k)
Blackman Samuel C., HEAD OF R&D
10b5-1 planSold 2.7% of holdings ($16M position)1.1M shares left3x usual sizeFiling
- 4 Form 4 sale DAWNRoutineOct 31 +51 days
Sold 500 shares at $16.02 ($8k)
Blackman Samuel C., HEAD OF R&D
10b5-1 planSold 0% of holdings ($17.6M position)1.1M shares left0.1x usual sizeFiling
- 5 Form 4 sale DAWNRoutineNov 7 +7 days
Sold 11,245 shares at $16.03 ($180k)
Blackman Samuel C., HEAD OF R&D
10b5-1 planSold 1% of holdings ($17.6M position)1.1M shares left1.1x usual sizeFiling
- 6 Form 4 sale DAWNRoutineNov 11 +4 days
Sold 28,255 shares at $16.15 ($456k)
Blackman Samuel C., HEAD OF R&D
10b5-1 planSold 2.6% of holdings ($17.5M position)1.1M shares left2.8x usual sizeFiling
- 7 Form 4 sale DAWNNo planNov 18 +7 days
Sold 2,206 shares at $13.21 ($29k)
Blackman Samuel C., HEAD OF R&D
No 10b5-1 planSold 0.2% of holdings ($14.1M position)1.1M shares left0.2x usual sizeFiling
- 8 Form 4 sale DAWNUnusualDec 10 +22 days
Sold 30,000 shares at $13.31 ($399k)
Blackman Samuel C., HEAD OF R&D
10b5-1 planSold 2.8% of holdings ($14.2M position)1M shares left3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (38)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Dec 10, 2024 | DAWN | HEAD OF R&D | Form 4 sale | 30,000 | $399k | 2.8% | Unusual | SEC |
| Nov 18, 2024 | DAWN | HEAD OF R&D | Form 4 sale | 2,206 | $29k | 0.2% | No plan | SEC |
| Nov 11, 2024 | DAWN | HEAD OF R&D | Form 4 sale | 28,255 | $456k | 2.6% | Routine | SEC |
| Nov 7, 2024 | DAWN | HEAD OF R&D | Form 4 sale | 11,245 | $180k | 1.0% | Routine | SEC |
| Oct 31, 2024 | DAWN | HEAD OF R&D | Form 4 sale | 500 | $8k | 0.0% | Routine | SEC |
| Sep 10, 2024 | DAWN | HEAD OF R&D | Form 4 sale | 30,000 | $427k | 2.7% | Unusual | SEC |
| Aug 16, 2024 | DAWN | HEAD OF R&D | Form 4 sale | 2,232 | $31k | 0.2% | No plan | SEC |
| Jul 16, 2024 | DAWN | HEAD OF R&D | Form 4 sale | 20,000 | $320k | 1.8% | Routine | SEC |
| Jun 10, 2024 | DAWN | HEAD OF R&D | Form 4 sale | 30,000 | $379k | 2.6% | Unusual | SEC |
| May 16, 2024 | DAWN | HEAD OF R&D | Form 4 sale | 2,267 | $36k | 0.2% | No plan | SEC |
| May 10, 2024 | DAWN | HEAD OF R&D | Form 4 sale | 10,000 | $164k | 0.9% | Routine | SEC |
| Apr 18, 2024 | DAWN | HEAD OF R&D | Form 4 sale | 10,000 | $160k | 0.8% | Routine | SEC |
| Mar 25, 2024 | DAWN | HEAD OF R&D | Form 4 sale | 10,000 | $160k | 0.8% | Routine | SEC |
| Mar 11, 2024 | DAWN | HEAD OF R&D | Form 4 sale | 30,000 | $457k | 2.4% | Unusual | SEC |
| Feb 27, 2024 | DAWN | HEAD OF R&D | Form 4 sale | 20,000 | $322k | 1.6% | Routine | SEC |
| Feb 27, 2024 | DAWN | Officer | Form 144 notice | 80,000 | $1.3M | Notice | SEC | |
| Feb 16, 2024 | DAWN | HEAD OF RESEARCH AND DEVELOPME | Form 4 sale | 2,258 | $34k | 0.2% | No plan | SEC |
| Nov 16, 2023 | DAWN | Head of Research and Developme | Form 4 sale | 709 | $8k | 0.1% | No plan | SEC |
| Aug 17, 2023 | DAWN | Head of Research and Developme | Form 4 sale | 668 | $9k | 0.1% | No plan | SEC |
| Jun 5, 2023 | DAWN | Chief Medical Officer | Form 4 sale | 1,229 | $20k | 0.1% | No plan | SEC |
| Jun 5, 2023 | DAWN | Officer | Form 144 notice | 10,000 | $136k | Notice | SEC | |
| May 16, 2023 | DAWN | Chief Medical Officer | Form 4 sale | 692 | $9k | 0.1% | No plan | SEC |
| May 16, 2023 | DAWN | Officer | Form 144 notice | 692 | $9k | Notice | SEC | |
| Mar 10, 2023 | DAWN | Chief Medical Officer | Form 4 sale | 10,000 | $181k | 0.8% | Plan not stated | SEC |
| Feb 16, 2023 | DAWN | Chief Medical Officer | Form 4 sale | 674 | $13k | 0.1% | Plan not stated | SEC |
| Feb 10, 2023 | DAWN | Chief Medical Officer | Form 4 sale | 10,000 | $201k | 0.8% | Plan not stated | SEC |
| Jan 10, 2023 | DAWN | Chief Medical Officer | Form 4 sale | 10,000 | $229k | 0.8% | Plan not stated | SEC |
| Dec 1, 2022 | DAWN | Chief Medical Officer | Form 4 sale | 10,000 | $215k | 0.8% | Plan not stated | SEC |
| Nov 16, 2022 | DAWN | Chief Medical Officer | Form 4 sale | 377 | $8k | 0.0% | Plan not stated | SEC |
| Nov 1, 2022 | DAWN | Chief Medical Officer | Form 4 sale | 10,000 | $200k | 0.8% | Plan not stated | SEC |
| Oct 3, 2022 | DAWN | Chief Medical Officer | Form 4 sale | 10,000 | $200k | 0.8% | Plan not stated | SEC |
| Sep 1, 2022 | DAWN | Chief Medical Officer | Form 4 sale | 10,000 | $232k | 0.8% | Plan not stated | SEC |
| Aug 16, 2022 | DAWN | Chief Medical Officer | Form 4 sale | 941 | $23k | 0.1% | Plan not stated | SEC |
| Aug 1, 2022 | DAWN | Chief Medical Officer | Form 4 sale | 10,000 | $169k | 0.8% | Plan not stated | SEC |
| Jul 1, 2022 | DAWN | Chief Medical Officer | Form 4 sale | 10,000 | $187k | 0.8% | Plan not stated | SEC |
| Jun 15, 2022 | DAWN | Chief Medical Officer | Form 4 sale | 50,000 | $813k | 3.7% | Plan not stated | SEC |
| Jan 3, 2022 | DAWN | Chief Medical Officer | Form 4 sale | 10,000 | $171k | 0.7% | Plan not stated | SEC |
| Dec 1, 2021 | DAWN | Chief Medical Officer | Form 4 sale | 10,000 | $172k | 0.7% | Plan not stated | SEC |